483 Strides Pharma Global Pte Feb 2019

483 Strides Pharma Global Pte Feb 2019

Anastasia Shields FDA$119.00 - Available Now

FDA investigators audited the Strides Pharma Global Pte - Singapore, Singapore facility and issued inspectional observations (via FDA 483) on 01 Feb 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 01 Feb 2019
  • Location: Singapore, Singapore
  • FEI: 3012423830
Add To Cart